Halaven
Drug timelines are a Plus or Pro feature.
53 regulatory and trial events tracked for Halaven, covering 2010-11-15 to 2026-04-03. Get the full timeline:
Most recent: Clinical Trial Update: Tucatinib+Trastuzumab+Eribulin in HER2+ MBC [Phase 2]